-
1
-
-
0025061721
-
The frequency of uterine leiomyomas
-
Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438.
-
(1990)
Am J Clin Pathol
, vol.94
, pp. 435-438
-
-
Cramer, S.F.1
Patel, A.2
-
2
-
-
0028232076
-
Hysterectomy in the United States, 1988-1990
-
Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-555.
-
(1994)
Obstet Gynecol
, vol.83
, pp. 549-555
-
-
Wilcox, L.S.1
Koonin, L.M.2
Pokras, R.3
Strauss, L.T.4
Xia, Z.5
Peterson, H.B.6
-
3
-
-
0031559434
-
Hysterectomy surveillance-United States, 1980-1993
-
Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 1997;46:1-15.
-
(1997)
MMWR CDC Surveill Summ
, vol.46
, pp. 1-15
-
-
Lepine, L.A.1
Hillis, S.D.2
Marchbanks, P.A.3
Koonin, L.M.4
Morrow, B.5
Kieke, B.A.6
Wilcox, L.S.7
-
4
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330:1304-1305.
-
(2005)
BMJ
, vol.330
, pp. 1304-1305
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
Alessi, D.R.4
Morris, A.D.5
-
5
-
-
33645766204
-
Increased cancerrelated mortality for patients with type 2 diabetes who use sulfonylureas or insulin
-
Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancerrelated mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006;29:254-258.
-
(2006)
Diabetes Care
, vol.29
, pp. 254-258
-
-
Bowker, S.L.1
Majumdar, S.R.2
Veugelers, P.3
Johnson, J.A.4
-
6
-
-
33751284806
-
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
-
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 2006;66:10269-10273.
-
(2006)
Cancer Res
, vol.66
, pp. 10269-10273
-
-
Zakikhani, M.1
Dowling, R.2
Fantus, I.G.3
Sonenberg, N.4
Pollak, M.5
-
7
-
-
0345447402
-
Hormone responsive human breast cancer in long-term tissue culture: Effect of insulin
-
Osborne CK, Bolan G, Monaco ME, Lippman ME. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci USA 1976;73:4536-4540.
-
(1976)
Proc Natl Acad Sci USA
, vol.73
, pp. 4536-4540
-
-
Osborne, C.K.1
Bolan, G.2
Monaco, M.E.3
Lippman, M.E.4
-
8
-
-
34047174592
-
The role of insulin receptor isoforms and hybrid insulin/ IGF-I receptors in human cancer
-
Belfiore A. The role of insulin receptor isoforms and hybrid insulin/ IGF-I receptors in human cancer. Curr Pharm Des 2007;13:671-686.
-
(2007)
Curr Pharm des
, vol.13
, pp. 671-686
-
-
Belfiore, A.1
-
9
-
-
68049140801
-
Comparison of human and rat uterine leiomyomata: Identification of a dysregulated mammalian target of rapamycin pathway
-
Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, Wilson E, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res 2009;69:6171-6178.
-
(2009)
Cancer Res
, vol.69
, pp. 6171-6178
-
-
Crabtree, J.S.1
Jelinsky, S.A.2
Harris, H.A.3
Choe, S.E.4
Cotreau, M.M.5
Kimberland, M.L.6
Wilson, E.7
-
10
-
-
0029004364
-
Rodent model of reproductive tract leiomyomata. Clinical and pathological features
-
Everitt JI, Wolf DC, Howe SR, Goldsworthy TL, Walker C. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol 1995;146:1556-1567.
-
(1995)
Am J Pathol
, vol.146
, pp. 1556-1567
-
-
Everitt, J.I.1
Wolf, D.C.2
Howe, S.R.3
Goldsworthy, T.L.4
Walker, C.5
-
11
-
-
0029036505
-
Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines
-
Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 1995;146:1568-1579.
-
(1995)
Am J Pathol
, vol.146
, pp. 1568-1579
-
-
Howe, S.R.1
Gottardis, M.M.2
Everitt, J.I.3
Goldsworthy, T.L.4
Wolf, D.C.5
Walker, C.6
-
12
-
-
0028808840
-
Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo
-
Howe SR, Gottardis MM, Everitt JI, Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 1995;136:4996-5003.
-
(1995)
Endocrinology
, vol.136
, pp. 4996-5003
-
-
Howe, S.R.1
Gottardis, M.M.2
Everitt, J.I.3
Walker, C.4
-
13
-
-
0030915898
-
Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k
-
Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J 1997;16:3693-3704.
-
(1997)
EMBO J
, vol.16
, pp. 3693-3704
-
-
Jefferies, H.B.1
Fumagalli, S.2
Dennis, P.B.3
Reinhard, C.4
Pearson, R.B.5
Thomas, G.6
-
14
-
-
67650514082
-
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
-
Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009;8:2031-2040.
-
(2009)
Cell Cycle
, vol.8
, pp. 2031-2040
-
-
Liu, B.1
Fan, Z.2
Edgerton, S.M.3
Deng, X.S.4
Alimova, I.N.5
Lind, S.E.6
Thor, A.D.7
-
15
-
-
65849256893
-
Metformin induces apoptosis of pancreatic cancer cells
-
Wang LW, Li ZS, Zou DW, Jin ZD, Gao J, Xu GM. Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 2008;14:7192-7198.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 7192-7198
-
-
Wang, L.W.1
Li, Z.S.2
Zou, D.W.3
Jin, Z.D.4
Gao, J.5
Xu, G.M.6
-
16
-
-
61449113987
-
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase
-
(Phila)
-
Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila) 2008;1:369-375.
-
(2008)
Cancer Prev Res
, vol.1
, pp. 369-375
-
-
Zakikhani, M.1
Dowling, R.J.2
Sonenberg, N.3
Pollak, M.N.4
-
17
-
-
47249088612
-
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
-
Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol 2008;110:246-250.
-
(2008)
Gynecol Oncol
, vol.110
, pp. 246-250
-
-
Gotlieb, W.H.1
Saumet, J.2
Beauchamp, M.C.3
Gu, J.4
Lau, S.5
Pollak, M.N.6
Bruchim, I.7
-
19
-
-
42949139481
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint
-
Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008;30:214-226.
-
(2008)
Mol Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
Mihaylova, M.M.4
Mery, A.5
Vasquez, D.S.6
Turk, B.E.7
Shaw, R.J.8
-
20
-
-
65349175605
-
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
-
Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 2009;8:909-915.
-
(2009)
Cell Cycle
, vol.8
, pp. 909-915
-
-
Alimova, I.N.1
Liu, B.2
Fan, Z.3
Edgerton, S.M.4
Dillon, T.5
Lind, S.E.6
Thor, A.D.7
-
21
-
-
58149354390
-
Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1
-
Zhuang Y, Miskimins WK. Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 2008;3:18.
-
(2008)
J Mol Signal
, vol.3
, pp. 18
-
-
Zhuang, Y.1
Miskimins, W.K.2
-
22
-
-
75149162547
-
Metformin: An old medication of new fashion: Evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
-
Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 2010;162:193-212.
-
(2010)
Eur J Endocrinol
, vol.162
, pp. 193-212
-
-
Diamanti-Kandarakis, E.1
Christakou, C.D.2
Kandaraki, E.3
Economou, F.N.4
-
23
-
-
60549105378
-
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review
-
Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009;30:1-50.
-
(2009)
Endocr Rev
, vol.30
, pp. 1-50
-
-
Palomba, S.1
Falbo, A.2
Zullo, F.3
Orio Jr., F.4
|